Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis.
Multiple Sclerosis and Related Disorders(2019)
Abstract
•Higher levels of acid sphingomyelinase activity in MS patients were found.•Acid sphingomyelinase activity did not correlate with activity, progression or therapy response.•Two ceramides and four types of sphingomyelin require further investigation as potential markers.
MoreTranslated text
Key words
Multiple sclerosis,Biomarkers,Sphingomyelins,Sphingolipids,Fingolimod
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined